Difference between revisions of "MULTIPLE SCLEROSIS-PROGNOSIS"
(Imported from text file) |
(Imported from text file) |
||
| Line 3: | Line 3: | ||
<br/>1. Female sex | <br/>1. Female sex | ||
<br/>2. Age < 35 yrs | <br/>2. Age < 35 yrs | ||
<br/>3. Sensory or optic neuritis as the first presentation | <br/>3. Sensory or optic neuritis as the first presentation | ||
<br/>4. Sudden onset of symptoms & almost complete recovery | <br/>4. Sudden onset of symptoms & almost complete recovery | ||
<br/>5. Long remission of symptoms | <br/>5. Long remission of symptoms | ||
<br/> | <br/> | ||
| Line 12: | Line 10: | ||
<br/>1. Male sex | <br/>1. Male sex | ||
<br/>2. Age > 35 yrs | <br/>2. Age > 35 yrs | ||
<br/>3. Initial motor or cerebellar dysfunction | <br/>3. Initial motor or cerebellar dysfunction | ||
<br/>4. Rapid progression of disease | <br/>4. Rapid progression of disease | ||
Latest revision as of 02:29, 21 March 2023
SUMMARY
GOOD PROGNOSTIC MARKERS
1. Female sex
2. Age < 35 yrs
3. Sensory or optic neuritis as the first presentation
4. Sudden onset of symptoms & almost complete recovery
5. Long remission of symptoms
POOR PROGNOSIS
1. Male sex
2. Age > 35 yrs
3. Initial motor or cerebellar dysfunction
4. Rapid progression of disease
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
